Clinical and genetic characterization of Netherton syndrome due to SPINK5 founder variant in Latvian population
Pediatric Allergy and Immunology · 2023
DOI: 10.1111/pai.13937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2023. Verfasst von Inga Nartisa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Riga Stradins University, Riga, Latvia. Hauptthemen laut MEDLINE: Netherton Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Netherton syndrome (NS) (OMIM:256500) is a very rare autosomal recessive multisystem disorder mostly affecting ectodermal derivatives (skin and hair) and immune system. It is caused by biallelic loss‐of‐function variants in the SPINK5 gene, encoding the protease inhibitor lymphoepithelial Kazal‐type‐related inhibitor (LEKTI). Material, Methods and Results Here, we describe NS clinical and genetic features of homogenous patient group: 9 individuals from 7 families with similar ethnic background and who have the same SPINK5 variant (NM_006846.4: c.1048C > T, p.(Arg350*)) in homozygous or compound heterozygous states, suggesting that it is a common founder variant in Latvian population. Indeed, we were able to show that the variant is common in general Latvian population, and it shares the same haplotype among the NS individual. It is estimated that the variant arose >1000 years ago. Clinically, all nine patients exhibited typical NS skin changes (scaly erythroderma, ichthyosis linearis circumflexa , itchy skin), except for one patient who has a different skin manifestation—epidermodysplasia. Additionally, we show that developmental delay, previously underrecognized in NS, is a common feature among these patients.
Conclusions
This study shows that the phenotype of NS individuals with the same genotype is highly homogeneous.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Riga Stradins University, Riga, Latvia.
- Children's Clinical University Hospital, Riga, Latvia.
- Clinic for Medical Genetics and Prenatal Diagnosis, Children's Clinical University Hospital, Riga, Latvia.
- Pauls Stradins Clinical University Hospital, Riga, Latvia.
- Radboudumc, Nijmegen, The Netherlands.
ORCID-Profile: Inga Nartisa
Zitieren
APA
Nartisa, I., Kirsteina, R., Neiburga, K. D., Zigure, S., Ozola, L., Grantina, I., Micule, I., Murmane, D., Slisere, B., Gailite, L., Vilne, B., Rots, D., Taurina, G., & Kurjane, N. (2023). Clinical and genetic characterization of Netherton syndrome due to SPINK5 founder variant in Latvian population. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.13937
Vancouver
Nartisa I, Kirsteina R, Neiburga KD, Zigure S, Ozola L, Grantina I, et al. Clinical and genetic characterization of Netherton syndrome due to SPINK5 founder variant in Latvian population. Pediatric Allergy and Immunology. 2023. doi:10.1111/pai.13937
BibTeX
@article{Nartisa2023,
author = {Nartisa, Inga and Kirsteina, Rasa and Neiburga, Katrina Daila and Zigure, Sanita and Ozola, Lota and Grantina, Ineta and Micule, Ieva and Murmane, Daiga and Slisere, Baiba and Gailite, Linda and Vilne, Baiba and Rots, Dmitrijs and Taurina, Gita and Kurjane, Natalja},
title = {Clinical and genetic characterization of Netherton syndrome due to SPINK5 founder variant in Latvian population},
journal = {Pediatric Allergy and Immunology},
year = {2023},
doi = {10.1111/pai.13937}
}
EUVIMED